InsidersTradesSigma
Track the Zymeworks BC Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.6bn. The latest transaction was disclosed on 14 November 2022 (Levée d'options). Among the most active insiders: Josephson Neil. The full history is openly available.
Analysts rate Zymeworks BC Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$39.33.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Zymeworks BC Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias basadas en proteínas para el tratamiento del cáncer y otras enfermedades. Cotiza en NASDAQ bajo el símbolo ZYME.